26-A-19859-ACC HS235, A NEXT-GENERATION BMP-9/-10-SPARING ACTIVIN SIGNALING INHIBITOR FOR THE TREATMENT OF PULMONARY HYPERTENSION (PH) AND HEART FAILURE: RESULTS FROM A PHASE 1 HEALTHY VOLUNTEER TRIAL DEMONSTRATING FAVOURABLE SAFETY AND PHARMACODYNAMIC EFFECTS